ArticleResearch square2026
Does Socioeconomic Status Moderate the Association Between Metabolic Syndrome and Cognitive Decline? A Moderated Mediation Analysis Using the China Health and Retirement Longitudinal Study (CHARLS).
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic syndrome (MetS) has been associated with cognitive decline, yet the role of socioeconomic status (SES) in modifying this association through inflammatory pathways remains unclear. This study investigated whether SES moderates the mediating effect of C-reactive protein (CRP) in the MetS-cognitive decline pathway. Methods: We used longitudinal data from the China Health and Retirement Longitudinal Study (CHARLS) spanning 2011-2018. The final analytic sample comprised 2,357 participants (aged ≥ 45 years, baseline stroke-free, with complete MetS, cognitive function, SES, and 2015 CRP data). MetS was defined using the IDF Asian criteria. Cognitive decline was operationalized as the difference between 2011 and 2018 total cognitive scores. An SES index was constructed from standardized education years and household income. A moderated mediation model with log(CRP + 1) at 2015 as the mediator was tested using 5,000 bootstrap resamples. Sensitivity analyses included continuous MetS component count, education-only SES, and exclusion of CRP > 10 mg/L. Results: Among 2,357 participants (29.6% with MetS, mean age 58.2 years), MetS significantly predicted higher CRP levels (β = 0.120, Conclusions: Although MetS elevates systemic inflammation as indexed by CRP, the CRP pathway does not significantly mediate the effect of MetS on cognitive decline, and this indirect effect is not moderated by SES. SES independently and strongly predicts cognitive decline trajectories, suggesting that socioeconomic factors may influence cognitive aging through pathways beyond metabolic inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.